Immuno-oncology Clinical Trial Market Size Estimation and Future Growth Analysis 2026–2035
The global Immuno-oncology Clinical Trial Market was valued at USD 11.3 billion in 2025 and is expected to reach USD 38.1 billion by the end of 2035, growing at around 12.9% CAGR during the forecast period. The market is expanding rapidly as pharmaceutical and biotechnology companies increase investment in therapies that activate, enhance, or redirect the immune system to recognize and eliminate cancer cells.
